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A Region in the CD8 Gene Locus
That Directs Expression to the Mature
CD8 T Cell Subset in Transgenic Mice
Arnd Hostert, Mauro Tolaini, been associated not only with the ability of the CD8
molecule to bind the nonpolymorphic region of majorKathleen Roderick, Nicola Harker,
histocompatibility (MHC) class I molecules, thus en-Trisha Norton, and Dimitris Kioussis*
hancing the formation of stable T cell receptor (TCR)±Division of Molecular Immunology
MHC class I interactions (Garcia et al., 1996), but alsoNational Institute for Medical Research
with its capacity to interact with the lymphocyte-The Ridgeway
restricted cytoplasmic tyrosine kinase p56lck (VeilletteMill Hill
et al., 1988; Barber et al., 1989; Zamoyska et al., 1989),London, NW7 1AA
thereby inducing intracellular signaling.England
The CD8 gene locus, located on chromosome 6 in the
mouse (Itakura et al., 1972; Gottlieb, 1974), consists of
two genes, CD8a and CD8b, separated by 36 kb thatSummary
are organized in the same transcriptional orientation
(Gorman et al., 1988). The murine CD8 gene locus wasThe coreceptors CD4 and CD8 play a crucial role
cloned from genomic P1 and cosmid libraries, and miceduring thymocyte development and T cell effector
transgenic for the insert of one of the isolated P1 clones,function, and their expression is developmentally reg-
P1±5, were generated (Hostert et al., 1997). Our dataulated. To determine the underlying molecular mecha-
showed that the 80 kb injected fragment containing thenisms of CD8 gene regulation we cloned the murine
CD8a and CD8b genes carries sufficient information toCD8 gene locus from genomic libraries and analyzed
direct subset-specific and developmentally regulatedthis region for deoxyribonuclease (DNase I) hypersen-
expression of the transgenic CD8 gene locus. Deoxyri-sitive sites (HSS). Here we report, using transgenic
bonuclease I (DNase I) hypersensitive site (HSS) analysismice, deletion analysis of one of the identified clusters
was carried out on the cloned region using DNA isolatedof DNase I hypersensitivity, consisting of three DNase
from DNase I±treated thymocyte nuclei. Three thymo-I±HSS and located in the intergenic region between
cyte-specific clusters of DNase I±HSS located in thethe CD8a and CD8b genes. Our data show that at least
intergenic region between the CD8a and CD8b genestwo of the DNase I±HSS constituting this cluster are
were identified (Hostert et al., 1997).individually sufficient to direct CD8a or heterologous
In addition to our own studies, DNase I±HSS mappingtransgene expression to the mature CD8 single-posi-
has been carried out by others on the human CD8ative T cell subset and that this expression coincides
(hCD8a) and mouse CD8a gene, identifying several tis-temporally with the appearance of positively selected
sue-specific DNase I±HSS (Hambor et al., 1993; LandryT cells.
et al., 1993). This has led to the identification of potential
transcriptional control elements located within the lastIntroduction
intron of the hCD8a gene (Hambor et al., 1993; Hanke
et al., 1995) and a decameric sequence in the hCD8a
Helper and cytotoxic T lymphocyte function depends
promoter that resembles the cyclic AMP response ele-
on coreceptor molecules, CD4 and CD8 respectively,
ment (Gao and Kavathas, 1993) and that contains DNA-
the expression of which is developmentally regulated.
binding sites for transcription factors that have been
In mature T cell subsets their expression is mutually
implicated in T cell±specific gene expression. Landry
exclusive, whereas these molecules are coexpressed
and coworkers (1994) identified three CD8-specific DNase
on the majority of immature thymocytes. Prothymocytes I±HSS located upstream of the murine CD8a gene.
enter the thymus as cells negative for CD4 and CD8
These sites coincide with the cluster CII DNase I±HSS
(double negative [DN]). Subsequently these cells ex-
described by us (Hostert et al., 1997). One of these sites
press both coreceptors on their cell surface to become
(DNase I±HSS CII-1) was shown to contain binding sites
CD41CD81 (double positive [DP]). Following selection for the T lymphocyte±restricted transcription factor
and further maturation, one of the two coreceptors is GATA-3 and was found to be functional in a transient
down-regulated (reviewed by Fowlkes and Pardoll, transfection assay using a minimal c-fospromoter linked
1989), and thecells become single positive (SP) for either to a CAT reporter gene (Landry et al., 1993). Further
CD4 or CD8 and migrate into the peripheral lymphoid work on potential CD8 regulatory elements by Lee and
organs. coworkers (1994) identified an element with negative
The murine CD8 cell surfaceglycoprotein isexpressed regulatory function on CD8a gene expression in a
predominantly as a disulphide-bonded heterodimeric transfected thymoma cell line and located close to one
molecule composed of an a and a b chain (Jay et al., of the CD8 upstream DNase I±HSS identified by Landry
1982; Ledbetter and Seaman, 1982; Ledbetter et al., et al. (1993) (DNase I±HSS CII-1; see Figure 2 below).
1981), and the expression of both is critical for the devel- In this article we report the deletion analysis of one of
opment of the cytotoxic T cell lineage (Fung-Leung et the clusters of DNase I±HSS located 16 kb upstream
al., 1991; Crooks and Littman, 1994; Itano et al., 1994; of the CD8a gene (DNase I±HSS CIII). The whole group
Nakayama et al., 1994). The role of these molecules has of DNase I±HSS or individual DNase I±HSS constituting
cluster CIII were linked to two reporter genes, CD8a or
human CD2 (hCD2), and lymphocytes from transgenic*To whom correspondence should be addressed.
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Figure 1. DNase I±HSS Cluster CIII Consists
of Three DNase I±HSS
(A) Genomic size markers were generated by
digestion of DNA isolated from splenocytes
with a range of restriction enzymes in double
digests (indicated above the lanes). This blot
was hybridized with probe A (see panel E).
Sizes (in kilobases) of hybridizing fragments
are indicated at left. For fine mapping of clus-
ter CIII DNase I±HSS, DNA was isolated from
DNase I±treated thymocyte nuclei and di-
gested to completion either with HindIII or
in a separate double digest with EcoRV and
BamHI.
(B±D) Increasing DNase I concentration is in-
dicated above the lanes. The leftmost lane
contains DNase I±untreated DNA.
(B) Hybridization of probe A to DNase I±treated
thymocyte DNA digested with HindIII. DNase
I±HSS CIII-1 (hatched box). Asterisk, the
cross-hybridizing 0.7 kb HindIII fragment. (C)
Hybridization of probe B to DNase I±treated
thymocyte DNA digested with EcoRV and
BamHI. Hatched box, DNase I±HSS CIII-2.
(D) Hybridization of probe C to DNase I±treated
thymocyte DNA digested with HindIII. Hatched
box, DNase I±HSS CIII-3.
(E) Map of the genomic region containingHSS
cluster CIII. Vertical bars, restriction enzyme
sites; bold horizontal lines underneath the re-
striction map, probes A to C; lightface hori-
zontal arrow underneath each probe, the hy-
bridizing fragment generated by a restriction
enzyme site and the inferred DNase I±HSS;
vertical arrows labeled CIII-1 to CIII-3, the
location of DNase I±HSS identified in (B)
through (D).
mice generated with these constructs were analyzed by from DNase I±treated thymocyte nuclei digested with
fluorescence-activated cell sorting (FACS). Results from HindIII or EcoRV±BamHI. In addition, DNA isolated from
13 independent transgenic mouse lines showed subset- untreated splenocytes was digested in separate double
specific expression of the reporter genes to the CD81 digests with EcoRV±HindIII, HindIII±BglII, EcoRV±AccI,
SP mature T cell subset and indicated that at least two EcoRV±ApaI, and EcoRV±BamHI. These digests were
of the three DNase I±HSS in this cluster are individually used to generate genomic fragments of known sizes
sufficient to confer this pattern of expression on the when hybridized with probe A (Figures 1A and 1E) and
reporter gene. Furthermore, a temporal correlation be- therefore provide molecular markers of accurate size.
tween positive selection and onset of transgene expres- The DNase I±treated thymocyte DNA digested with
sion under the control of these sequences was ob- HindIII was hybridized with probe A, which hybridizes
served. to the 3.3 kb parent HindIII fragment and with increasing
DNase I concentration to additional fragments of ap-
proximately 1.6 kb absent in the zero DNase I lane (Fig-Results
ure 1B). This region of DNase I hypersensitivity was
designated DNase I±HSS CIII-1 (Figure 1E). It was alsoDNase I±HSS Cluster CIII Consists
observed that this probe hybridizes with lower intensityof Three DNase I±HSS
to a second HindIII fragment of 0.7 kb (asterisk, FigureDNase I±HSS cluster CIII was previously identified by
1B). This appears to be a cross-hybridizing restrictionlong-range mapping using XhoI and ScaI restriction di-
fragment rather than a DNase I±HSS since it is alsogests (Hostert et al., 1997). For further deletion analysis
visible in the zero DNase I lane. Probe B was hybridizedof this cluster, the exact location of the relative DNase
to the DNase I±treated thymocyte DNA double digestedI±HSS was determined by more detailed analysis.
with EcoRV±BamHI. This probe hybridizes to a 4.2 kbThree probes, a 0.9 kb EcoRV±HindIII (probe A), a 0.8
parent EcoRV±BamHI fragment and with increasingkb HindIII (probe B), and a 1.7 kb XbaI±ScaI (probe C)
fragment (Figure 1), were used to probe DNA isolated DNase I concentration to additional bands of 3.1 kb in
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size absent in the zero DNase I lane. This HSS was
designated DNase I±HSS CIII-2. The location of CIII-2
was reconfirmed by rehybridization of the blot with
probe A after removal of probe B (data not shown).
DNase I±HSS CIII-3 was mapped using probe C (Figure
1E). This probe was hybridized to DNase I±treated thy-
mocyte DNA digested with HindIII and was found to
hybridize to the 4.2 parent HindIII fragment (Figure 1E)
and with increasing DNase I concentration to 1.7 kb
fragments that are absent in the zero DNase I lane (Fig-
ure 1D). The location of this DNase I±HSS was also
reconfirmed with an additional probe, located close to
CIII-3 (data not shown).
Cluster CIII of DNase I±HSS Directs Expression
of Transgenes in the Mature CD81
SP T Cell Subset
Six independent transgenic mouse lines carrying con-
structs that contained a combination of DNase I±HSS
clusters CI and CII showed that these genomic regions
failed to direct transgene expression at all (data not
shown), consistent with observations made by other
groups (Zhang et al., 1994). We therefore focused on
the third cluster of DNase I±HSS (cluster CIII), located
Figure 2. DNase I±HSS CIII Deletion Constructs16 kb upstream from the CD8a gene (Figure 1E).
(A) Restriction map of the genomic CD8a gene locus showing theFor the generation of deletion constructs, DNase
location of the CD8a gene, its intron±exon structure (exons shownI±HSS cluster CIII was divided into three subfragments.
as filled boxes) and DNase I±HSS clusters CII and CIII (open andA 3.5 kb BamHI±EcoRV fragment that contains CIII-1, a
filled vertical arrows, respectively). DNase I±HSS of each cluster are
4.1 kb EcoRV±BamHI fragment that contains CIII-2, and labeled 1 to 3 with the exception of DNase I±HSS CII-3 of cluster
a 12 kb BamHI±ScaI fragment (Figure 1E) that contains CII, which has been labeled P (promoter) for clarity. Horizontal arrow
CIII-1, -2, and -3 and constructs were generated that beneath map, the transcriptional orientation of the CD8a gene.
(B±D) Deletion constructs generated for analysis in transgenic mice.included various combinations of the DNase I±HSS con-
All constructs include the CD8a/Lyt-2.2 allele of the CD8a genestituting cluster CIII (Figure 2). To address transgene
contained within a genomic 5.5 kb HindIII fragment. DNase I±HSSsexpression, we chose the CD8a/Lyt-2.2 allele encoded
were linked to the 59 sequence of the CD8a gene as cloned restric-by C57Bl/10 mice as a reporter gene. For this purpose
tion fragments retaining the naturally occuring orientations.
a HindIII genomic fragment encoding the CD8a/Lyt-2.2 (B) Deletion construct CD8a-CIII-123 containing all three cluster CIII
allele and encompassing 123 bp of 59 and 828 bp of 39 DNase I±HSS.
(C) Deletion construct CD8a-CIII-1 containing DNase I±HSS CIII-1sequences was used. This fragment has previously been
as a 3.5 kb BamHI±EcoRV fragment.shown to be sufficient for expressing the CD8a mRNA
(D) Deletion construct CD8a-CIII-2 containing DNase I±HSS CIII-2and protein in transfected L cells and transgenic mice
as a 4.1 kb EcoRV±BamHI fragment.(Zamoyska et al., 1985; Hostert et al., 1997). The trans-
gene constructs were introduced into CBA/Ca non-
plots). Of CD8a/Lyt-2.11 SP cells, 48.4% expressed thetransgenic mice that express the CD8a/Lyt-2.1 allele,
transgene-encoded CD8a/Lyt-2.2 protein, whereas onlyallowing us to distinguish the transgene protein product
1.6% of CD41 SP cells were found to be CD8a/Lyt-from that of the endogenous gene locus through use of
2.2 positive. As was the case in all of the CD8a-CIIIallele-specific antibodies. Thus, a 12 kb BamHI±ScaI
transgenic mice generated and analyzed, detectable cellfragment containing all three CIII DNase I±HSS was
surface expression was absent from the CD42CD82 DNlinked to the 59 sequence of the genomic HindIII frag-
cell compartment (data not shown).ment that encodes the CD8a/Lyt-2.2 allele of the CD8a
To delineate whether all three DNase I±HSS of clustergene (CD8a-CIII-123) (Figure 2B).
CIII are required to confer this subset-specific expres-Two additional constructs carrying this reporter gene
sion pattern onto the CD8a gene, DNase I±HSS 3 wasand including either DNase I±HSS CIII-1 (CD8a-CIII-1)
deleted from the 39 end of cluster CIII. Five transgenicor DNase I±HSS CIII-2 (CD8a-CIII-2) of the CIII cluster
mice that carried both DNase I±HSS CIII-1 and CIII-2(Figures 2C and 2D, respectively) also were generated.
linked to the CD8a reporter gene were generated. TheLymph node cells from transgenic mice carrying the
CD8-CIII-12 transgenic mice expressed the transgenicCD8a-CIII transgene constructs were triple stained with
CD8a/Lyt-2.2 allele on as many as 40% of CD81 SPantibodies specific for CD8a/Lyt-2.1 (endogenous al-
peripheral blood lymphocytes at levels higher in thanlele), CD4, and CD8a/Lyt-2.2 (transgenic allele). Figure
(C57Bl/10 3 CBA/Ca)F1 nontransgenic control mice. To3A shows the FACS analysis of lymphocytes isolated
delineate which of these two DNase I±HSS is responsi-from a CD8a-CIII-123 founder transgenic mouse. T cell
ble for directing CD8 subset-specific expression, twosubsets, identified by plotting CD8a/Lyt-2.1 against
additional constructs were generated by linking eitherCD4, were gated as indicated and analyzed for expres-
sion of CD8a/Lyt-2.2 (histograms to the right of the dot DNase I±HSS CIII-1 or CIII-2 individually to the CD8a
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Figure 3. A Single Cluster CIII DNase I±HSS Is Sufficient to Direct Subset-Specific Expression of a Linked CD8a Transgene
FACS analysis of lymphocytes isolated from CD8a-CIII transgenic and (CBA/Ca 3 C57Bl/10)F1 nontransgenic control mice triple stained with
anti-CD8a/Lyt-2.1 (End, endogenous) anti-CD4, and anti-CD8a/Lyt-2.2 (Tg, transgenic) antibodies. CD4 and CD8 SP cell populations were
identified by plotting CD8a/Lyt-2.1 against CD4. Resulting cell populations were gated and analyzed for expression of the transgenic CD8a/
Lyt-2.2 allele (shown in the histograms next to the dot plots). Structures of the transgene constructs are shown to the right of the corresponding
FACS plots. Restriction enzyme sites shown are BamHI (B), EcoRV (E), HindIII (H), and ScaI (S). None of the HindIII sites within DNase I±HSS
cluster CIII sequences is shown (see Figure 1).
(A±C) FACS analysis of CD8a-CIII-123 (A), CD8a-CIII-1 (B), and CD8a-CIII-2 (C) transgenic mice. T cell populations were identified and analyzed
as described above. Detectable cell surface expression of the CD8a/Lyt-2.2 transgene product was found to be specifically present only in
the CD8a/Lyt-2.1±positive cell population.
(D) FACS analysis of a (CBA/Ca 3 C57Bl/10)F1 nontransgenic control mouse. Lymphocytes were analyzed as described above. Anti-CD8a/
Lyt-2.2 antibody staining could be observed only in the CD8a/Lyt-2.1±positive cell subset.
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reporter (Figures 2C and 2D). Four transgenic mouse the CD41CD8a/Lyt-2.11 DP and CD41CD8a/Lyt-2.12 SP
thymocyte subsets of the latter two mice.lines that carried the CD8a-CIII-1 construct were gener-
ated. Two of them expressed the transgene in the CD81 The expression pattern of the transgene-encoded
CD8a/Lyt-2.2 allele is therefore different from thatSP mature T cell subset (the remaining two did not ex-
press at detectable levels); Figure 3B shows the FACS observed in a (CBA/Ca 3 C57Bl/10)F1 nontransgenic
control mouse that expresses the endogenous CD8a-analysis of lymphocytes from one of the two mice. Cells
were stained with antibodies specific for CD8a/Lyt-2.1, Lyt-2.2 allele in the CD41CD8a/Lyt-2.11 DP thymocyte
subset (Figure 4E). It should be emphasized, however,CD4, and CD8a/Lyt-2.2. CD8a/Lyt-2.11 and CD41 SP T
cell populations were gated and analyzed for expres- that cell surface expression of the transgenic CD8a/Lyt-
2.2 allele was consistently absent from the CD41CD8a/sion of transgenic CD8a/Lyt-2.2. Of CD8a/Lyt-2.11 SP
cells, 24.5% were found to express the transgenic CD8a Lyt-2.12 SP thymocytes inall of theCD8a-CIII transgenic
mice. In total, of the nine mouse lines examined all wereallele, while cell surface expression was undetectable
in the CD41 SP subset (0.8%). Similarly, analysis of a found to express the CD8 transgene in a proportion of
the mature CD8 SP but not the immature DP thymocytetransgenic mouse carrying DNase I±HSS CIII-2 linked
to the CD8a reporter gene showed subset-specific ex- subsets.
pression of CD8a/Lyt-2.2 on 76.6% of CD8a/Lyt-2.11
cells, while CD41 SP cells were negative for cell surface
DNase I Hypsersensitive Site Cluster CIIIexpression of the transgene product (Figure 3C). Thus,
Directs Subset-Specific Expressionwith the exception of those CD8a/Lyt-2.11 SP cells that
of a Heterologous Transgenedo not express the transgenic CD8a/Lyt-2.2 allele, the
It is possible that CD8a/Lyt-2.2 transgene expressionpattern of transgene expression is identical to that seen
in the CD81 SP cell subset described above is due toin a (CBA/Ca 3 C57Bl/10)F1 nontransgenic control
regulatory elements within the body of the CD8a/Lyt-mouse (Figure 3D).
2.2 reporter gene itself and that the role of DNase I±HSSIn summary, 9 of 11 independent transgenic mouse
cluster CIII is to establish a transcriptionally competentlines carrying CD8a-CIII genes under the control of ele-
transgene array. To exclude this possibility, hCD2 wasments found in DNase I±HSS cluster CIII expressed the
used as a heterologous reporter gene. hCD2 transgenestransgene in a subset-specific manner in the mature
under the regulation of the hCD2 locus control regionCD81 T cells.
(LCR) are normally expressed on all T cell subsets and
thymocytes (Kamoun et al., 1981; Lang et al., 1988).
To test whether DNase I±HSS cluster CIII is by itselfDNase I±HSS Cluster CIII Is Not Able to Direct
Expression of the Transgenes in Immature sufficient to direct subset-specific expression of genes
linked to it, we replaced the pan-T cell hCD2 LCR withDP Thymocytes
To analyze transgene expression pattern during T cell the CD8 cluster CIII DNase I±HSS. For this purpose, we
made use of a hCD2 minigene consisting of exon 1, thedevelopment, thymocytes from CD8a-CIII transgenic
mice were stained with antibodies specific for CD8a/ first intron, fused exons 2±5, and 250 bp of 39 sequences
(Greaves et al., 1989; Lang et al., 1991). Whereas thisLyt-2.1, CD4, and CD8a/Lyt-2.2. Gated cell subsets were
analyzed for expression of the transgenic CD8a/Lyt-2.2 minigene is transcriptionally competent, in the absence
of the hCD2 LCR it cannot direct sufficient expression(Figure 4, histograms to the right of the dot plots). The
CD8a-CIII-123 transgenic mouse was found to express of the hCD2 protein on transgenic lymphocytes (Lang
et al., 1991). The hCD2 minigene was linked at the 39the transgene-encoded CD8a/Lyt-2.2 protein specifi-
cally in the CD81 SP (25% of gated cells) and to a lower end to DNase I±HSS cluster CIII, and the construct was
injected into the pronucleusof fertilized oocytes isolatedextent (14.5%) in the CD42CD82 DN thymocyte popula-
tions (Figure 4A). However, cell surface expression could from (CBA/Ca 3 C57Bl/10)F1 mice. Figure 5 shows FACS
analyses of a CD2-CIII-123 transgenic founder, an Mg4not be detected in the CD41CD8a/Lyt-2.11 DP or the
CD41CD8a/Lyt-2.12 SP cell subsets. Analysis of the control transgenic, and a CBA/Canontransgenic mouse.
Lymphocytes and thymocytes isolated from the CD2-CD8a-CIII-1 transgenic mouse showed a similar expres-
sion pattern, with 22.5% of CD8a/Lyt-2.11 SP thymo- CIII-123 transgenic founder mouse were triple stained
with antibodies specific for CD8, CD4, and hCD2 (Figurecytes expressing the transgene. In contrast to the CD8a-
CIII-123 mouse, no detectable transgene expression 5). CD81 and CD41 T cell subsets were identified by
plotting CD8 against CD4, gated as shown in the dotcould be observed in the CD42CD8a/Lyt-2.12 DN thy-
mocyte subset. plots and analyzed for hCD2 expression as shown in
the histograms to the right of the dot plots (Figure 5A).CD8a-CIII-2 transgenic mice showed a distribution of
transgene expression in the thymocyte subsets similar Detectable cell surface expression was specifically
present only on the CD81 cell subset with 35% of CD81to that in the CD8a-CIII-123 mice, with 57.5% of CD8a/
Lyt-2.11 SP thymocytes expressing the transgene. In cells expressing high levels of the transgenic hCD2. This
is in contrast to the Mg4 transgenic mice carrying theaddition and as observed in the CD8a-CIII-123 trans-
genic mice, a small proportion (11%) of CD42CD8a/ same hCD2 minigene under the control of the hCD2 LCR
expressing hCD2 on both the CD41 and CD81 T cellLyt-2.12 DN cells were found to express the transgenic
CD8a/Lyt-2.2 (Figure 4C). This thymocyte subset was subsets (Figure 5D).
Thymus analysis of these mice showed that, similarlyexamined furtherby four-color FACS analysis (see below
and Discussion). Similar to the CD8a-CIII-123 trans- to the CD8a-CIII-123 transgenic mice, expression of the
hCD2 transgene was detectable only in the CD81 SPgenic mouse, CD8a/Lyt-2.2 expression was absent from
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Figure 4. DNase I±HSS Cluster CIII Is Not Sufficient to Direct Transgene Expression to Immature CD41CD81 DP Thymocytes
Three-color fluorometric analysis of thymocytes isolated from CD8a-CIII transgenic and (CBA/Ca 3 C57Bl/10)F1 nontransgenic control mice.
Thymocytes were stained with anti-CD8a/Lyt-2.1 (End, endogenous) anti-CD4, and anti-CD8a/Lyt-2.2 (Tg, transgenic) antibodies. Thymocyte
subpopulations were identified by plotting CD8a/Lyt-2.1 against CD4, gated as indicated in the dot plots and analyzed for expression of the
transgenic CD8a/Lyt-2.2 allele (shown in the histograms next to the dot plots). Structures of the transgene constructs are shown to the right
of the corresponding FACS plots. Restriction enzyme sites shown are BamHI (B), EcoRV (E), HindIII (H), and ScaI (S). None of the HindIII sites
within DNase I±HSS cluster CIII sequences is shown (see Figure 1).
(A±C) FACS analysis of CD8a-CIII-123 (A), CD8a-CIII-1 (B), and CD8a-CIII-2 (C) transgenic mice. Thymocyte populations were identified and
analyzed as described above.
(D) FACS analysis of a (CBA/Ca 3 C57Bl/10)F1 nontransgenic control mouse. Thymocytes were analyzed as described above. Anti-CD8a/Lyt-
2.2 antibody staining could be only observed in the CD8a/Lyt-2.1 positive cell subsets.
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Figure 5. DNase I±HSS Cluster CIII Determines Subset-Specific Expression of an hCD2 Transgene
Three-color fluorometric analysis of peripheral lymphocytes and thymocytes of CD2-CIII-123 transgenic, Mg4 control transgenic, and CBA/
Ca nontransgenic control mice. Isolated lymph node cells or thymocytes were stained with anti-CD8a, anti-CD4, and anti-hCD2 antibodies.
Cell populations were identified by plotting CD8a against CD4 and gated as shown in the dot plots. Cell populations were then analyzed for
hCD2 expression (shown in the histograms next to the corresponding dot plots).
(A and B) FACS analysis of peripheral lymphocytes (A) and thymocytes (B) isolated from CD2-CIII-123 transgenic mice analyzed as described
above.
(C) Structure of the CD2-CIII-123 transgene. The three cluster CIII DNase I±HSS were linked to the 39 end of the hCD2 minigene, thereby
replacing the hCD2 LCR.
(D and E) FACS analysis of lymphocytes (D) and thymocytes (E) isolated from Mg4 transgenic (dot plots and solid lines in histograms) and
CBA/Ca nontransgenic (gray overlays in histograms) control mice. Analysis was carried out as described above.
(F) Structure of the transgene construct carried by the Mg4 transgenic control mice. This transgene is identical to the CD2-CIII-123 transgene
construct, with the exception of the 39 region where the CIII DNase I±HSS cluster has been replaced by the hCD2 LCR. Restriction enzyme
sites shown are BamHI (B), ClaI (C), EcoRV (E), HpaI (H), ScaI (S), and XbaI (X). An additional EcoRV site within the coding region of the hCD2
minigene is not shown.
thymocyte subset (21.8% of CD81 cells expressing the thymocytes isolated from CD8a-CIII-123 transgenic and
(CBA/Ca 3 C57Bl/10)F1 control mice were stained withtransgenic hCD2) and to some extent in the CD82CD42
DN (17%) subset and was absent from the CD41CD81 antibodies specific for CD8a, CD4, CD8a/Lyt-2.2, and
DP or the CD41CD82 SP subsets. In contrast and as abTCR (Figure 6). Thymocyte subsets were identified
expected, Mg4 control transgenic mice expressed hCD2 by plotting CD8a against CD4 (Figure 6, dot plots at left).
on all thymocyte populations (Figure 5E). Three more DP and CD81 SP thymocyte populations were gated as
transgenic lines carrying a hCD2 minigene under the indicated and analyzed for expression of CD8a/Lyt-2.2
control of the CIII-12 DNase I±HSS also expressed the and abTCR (dot plots at right). Figure 6A shows the
hCD2 protein in a similar manner as those described analysis of the CD8a-CIII-123 transgenic founder mouse.
above (data not shown). A fourth line expressed the Analysis of the gated CD81 SP cell subset showed that
transgene in all T cells. This outcome is not unexpected all transgene-positive cells also expressed high levels
in hybrid gene constructs and is possibly due to position of abTCR, equivalent to those on the transgene-negative
effects imposed by the site of transgene integration in CD81 SP mature thymocytes (Figure 6A, dot plot at
combination with the pan-T cell competent promoter of bottom right). CD8a/Lyt-2.2 transgene-positive cells
the hCD2 gene present in the construct. were absent from the DP thymocyte subset. Since the
anti-CD8a antibody used in this experiment does not
distinguish between the CD8a/Lyt-2.1 and CD8a/Lyt-Transgene-Positive T Cells Express Mature
Levels of abTCR, and Their Appearance 2.2 alleles, this staining would have caused all of the
CD8a/Lyt-2.2 transgene-positive cells to move into theCoincides with Positive Selection
To determine whether the thymocytes that express the CD81 SP gate, including those that fall in the DN thymo-
cyte gate when endogenous allele-specific antibodiesCD8a/Lyt-2.2 transgene carry a conventional abTCR,
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Analysis of a four-color staining of these thymocytes
with antibodies specific for CD8, CD4, CD8a/Lyt-2.2,
and abTCR showed that onset of expression of the
CD8a/Lyt-2.2 transgene is coincident with the up-regu-
lation of the abTCR in these cells (Figure 7B, gray over-
lays and solid lines, respectively, in histograms).
Discussion
The generation and FACS analysis of transgenic mice
carrying an 80 kb genomic fragment from the CD8 gene
locus showed that the DNA sequences contained in the
injected fragment are sufficient for the developmentally
regulated, tissue- and subset-specific expression of the
cloned CD8ab locus (Hostert et al., 1997). Deletion anal-
ysis of the CD8 gene locus generated DNA constructs
that included defined DNase I±HSS clusters, and these
were introduced into transgenic mice. Two different con-
structs of a CD8a/Lyt-2.2 reporter gene linked to the
DNase I±HSS clusters CI and CII failed to express in
six independent transgenic mouse lines. These results
show that, at least in transgenic mice, DNase I±HSS
clusters CI and CII appear to be insufficient in directing
expression of the included CD8a reporter gene, consis-
tent with the results of other groups (Zhang et al., 1994).
However, the possibility that these transgenes are si-
lenced by integration of the transgene arrays into a tran-
scriptionally silent locus cannot be excluded.
Cluster CIII and Expression in the Mature
CD81 SP Subset
In contrast, use of elements from DNase I±HSS cluster
CIII, located in the intergenic region between the CD8a
and CD8b genes, linked to a CD8a/Lyt-2.2 reportergene,
resulted in nine transgenic mouse lines with distinct
expression patterns. Thus, transgene constructs that
contain all or subsets of the cluster CIII DNase I±HSS
linked to the CD8a/Lyt-2.2 reporter gene direct and re-
strict the expression of the reporter gene only to the
appropriateperipheral lymphoid cell subset, namely ma-Figure 6. Transgene-Expressing Cells Carry Mature Levels of
ture CD81 SP cells. A similar pattern of expression wasabTCR
observed in four additional transgenic lines when a het-Four-color fluorometric analysis of thymocytes isolated from (A)
CD8a-CIII-123 transgenic and (B) (CBA/Ca 3 C57Bl/10)F1 non- erologous transgene (hCD2) was linked to the cluster
transgenic control mice. Thymocytes were stained with antibodies CIII DNase I±HSS region. Since in the latter case the
specific for anti-CD8a, anti-CD4, anti-CD8a/Lyt-2.2, and anti-abTCR. transgene is capable of normal expression in all T cell
Thymocyte subpopulations were identified by plotting CD8a against subsets, the restricted pattern of expression in the ma-
CD4 (dot plots at left). CD81CD41 (DP) and CD42CD81 (SP) cell
ture CD81 SP T cell subset can be attributed only topopulations were gated as indicated and analyzed for expression
transcriptional effects imposedby the CD8DNase I±HSSof CD8a/Lyt-2.2 and abTCR (top and bottom right dot plots, respec-
tively). cluster CIII and not to a posttranscriptional regulatory
mechanism.
In the case of CD4 gene expression, experiments by
several groups have identified pan-T cell±specific en-are used. Interestingly, no transgene-positive abTCR-
negative cells could be detected, indicating that the hancers upstream of the CD4 gene (Sawada and Litt-
man, 1991; Blum et al., 1993), and analysis of the CD4CD8a/Lyt-2.2±positive cells found in the DN gate in Fig-
ure 3A are TCR high. Figure 7 shows FACS analysis of a promoter has shown that the promoter contributes to
tissue-specific expression of the CD4 gene (Siu et al.,CD8a-CIII-2 transgenic mouse thymus. More restricted
gating of the thymocyte subsets identified by CD8a/ 1992; Salmon et al., 1993). Control of subset-specific
expression, however, has been shown to be due mainlyLyt-2.2 and CD4 shows that onset of CD8a/Lyt-2.2
transgene expression occurred in the CD4loCD8lo and to a regulatory element located within the first intron of
the CD4 gene, which acts as a transcriptional silencerCD4loCD81 populations that have recently been impli-
cated in the pathway of normal differentiation of CD81 in the DN and CD8 SP cell subsets (Sawada et al., 1994;
Siu et al., 1994). An element with similar function andSP cells (Suzuki et al., 1995; Lucas and Germain, 1996).
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Figure 7. Transgene Expression Coincides
with Positive Selection
(A) Thymocytes isolated from CD8a-CIII-2
transgenic mice were stained with antibodies
specific for CD8a/Lyt-2.1, CD4, and CD8a/
Lyt-2.2. Thymocyte populations were identi-
fied by plotting CD8a/Lyt-2.1 against CD4
and gated as shown in the dot plot. CD8a/
Lyt-2.2 transgene expression was then as-
sessed in the gated populations as shown in
the histograms.
(B) Thymocytes isolated from CD8a-CIII-2
transgenic mice werestained with anti-CD8a,
anti-CD4, anti-CD8a/Lyt-2.2 and anti-abTCR
antibodies. CD8 thymocyte subpopulations
as identified by CD4 and CD8 were gated
as indicated and analyzed for expression of
abTCR (solid lines, histograms) and trans-
genic CD8a/Lyt-2.2 (gray overlays, histo-
grams).
located in the first intron of the human CD4 gene has exclude the possibility that a posttranscriptional control
mechanism contributes to the subset-specific expres-also been indentified (Donda et al., 1996).
The expression of the hCD2 gene in only the CD81 sion of the CD8a gene.
SP cells when placed under the control of DNase I±HSS
cluster CIII, as well as the ability of the CD8a genomic Is Cluster CIII a Silencer?
Analysis of all the transgenic mice revealed that trans-fragment to express in CD41 T cells when placed under
the control of the hCD2 LCR, suggests that a major role genic CD8 or hCD2 reporter expression was strikingly
absent from the CD41CD81 DP cell compartment in thefor a negative regulatory element in the CD8a reporter
gene restricting its expression to the CD8a SP subset thymus, indicating that DNase I±HSS cluster CIII is not
sufficient to direct the program of expression exhibitedis unlikely. Nevertheless, observations of a posttran-
scriptional regulatory mechanism of hCD8a in a Jurkat by the endogenous CD8a gene in these cells. The ab-
sence of transgenic reporter gene expression from theT cell line (Gao et al., 1996) and a combination of both
transcriptional and mRNA stability mechanisms in hu- immature DP thymocyte cell compartment observed in
the CIII transgenic mice closely resembles that seen inman T lymphocytes stimulated with anti-CD3 antibodies
and phorbol myristate acetate (Paillard et al., 1990) have mice carrying human CD4 transgene constructs that
have deletions of either CD4 intronic sequences or otherbeen reported. Thus, at the moment, we cannot entirely
Immunity
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CD4-associated DNase I±HSS (Salmon et al., 1996; Ad- transgenes were not obtained. It is not clear at present
whether the concerted action of all three DNase I±HSSlam et al., 1997; Uematsu et al., 1997). The results of
these experiments show that the CD4 enhancer and is required for control of CD8a expression in theendoge-
nous locus. Experiments that delete selected DNasepromoter by themselvesare not sufficient for expression
of the transgene in the DP thymocyte population and I±HSS of cluster CIII from the gene locus are currently
underway. The absence of an LCR from the isolatedthat sequences located either within the first intron of
CD4, which are distinct from the CD4 silencer, or outside CD8 genomic sequences (Hostert et al., 1997) results in
subjection of the transgene to chromosomal positionof the CD4 gene itself are required for expression of
the transgene in immature thymocytes. Therefore it is effects (Festenstein et al., 1996). Therefore, it is not
surprising that in most of the CD8 transgenic mice onlyconceivable that the CD8 DNase I±HSS cluster CIII fulfills
a role similar to the CD4enhancers and that an additional a proportion of cells express the transgene.
element, located within the cloned P1±5 sequences, is
required for CD8 transgene expression in DP thymo-
Cluster CIII and Positive Selectioncytes in transgenic mice (Hostert et al, 1997). What dis-
Four-color FACS analysis using anti-CD8a, anti-CD4,tinguishes the cluster CIII region from a silencer is that
anti-CD8a/Lyt-2.2, and anti-abTCR antibodies con-the absence of the complete CIII region or any element
firmed that the transgene-positive lymphocytes and thy-from it has not yet led to transgenic mice expressing
mocytes express a conventional abTCR and have up-the transgene in the CD4 compartment; in addition, a
regulated TCR levels (Figure 6). It is intriguing that thehybrid construct containing the CD8a gene under the
onset of detectable CD8 transgene expression duringdual control of the hCD2 LCR and the cluster CIII region
thymocyte development coincides with the point atappears to be expressed in both CD41 and CD81 sub-
which the thymocytes up-regulate their abTCR and cor-sets (A. Hostert, unpublished data).
relates with those intermediate subsets that have been
associated with positively selected cells. In CD8-CIII-
Is Cluster CIII a Regulatory Element 123 and CD8-CIII-2 transgenic mice, a proportion of
of Another Gene? CD8a/Lyt-2.12CD42 DN thymocytes were also found to
It is possible that the cluster CIII DNase I±HSS is com- be expressing the transgenic CD8a/Lyt-2.2 allele; how-
posed of regulatory elements that belong to a gene ever, four-color analysis with the above antibody combi-
distinct from CD8a or CD8b. We have sequenced the nation suggests that these cells also have up-regulated
region comprising DNase I±HSS cluster CIII and found TCR levels. These cells were absent from the CD8a/Lyt-
open reading frames of more than 150 amino acids. 2.12CD42 DN cell subset in the periphery of the CD8-
However, analysis of these open reading frames in the CIII transgenic mice, and as yet the fate of the CD8
context of surrounding genomic sequences failed to transgene-expressing DN thymocytes is not clear. It is
identify possible splice donor or acceptor sites, and thus interesting that similar transgene-expressing cells have
they are unlikely to be protein-encoding sequences. We also been observed in mice transgenic for CD4 con-
are currently further examining this region for transcrip- structs in which either all introns (Salmon et al., 1996)
tional activity. or selected clusters of DNase I±HSS were deleted (Ad-
lam et al., 1997; Uematsu et al., 1997). Nevertheless,
since the CD8a allele is normally not expressed in theRedundancy of Information in Cluster CIII
A redundancy of the gene regulatory elements con- DN thymocyte compartment, it is possible that another
element, not included in our transgene constructs, istained within the DNase I±HSS cluster CIII has been
noted. This is similar to that observed in other control required to silence expression of the CD8a gene in these
cells. One such element may be that described by Leeelements such as the a-fetoprotein/albumin enhancers
and the human b-globin LCR. Godbout and coworkers et al. (1994), which has a negative regulatory role on
promoter activity on CD8a transcription in a transfected(1986) showed that three fragments isolated from the
intergenic region between the a-fetoprotein and albumin thymoma cell line.
Because 13 of 14 different transgenic lines using regu-genes are individually or in concert capable of enhanc-
ing transcription of reporter gene constructs when latory regions from cluster CIII of DNase I±HSS from
the CD8 gene locus direct expression of linked reportertransfected into a human hepatoma cell line. A similar
modularity of gene regulatory control elements has also genes to the SP mature CD81 T cell subset, we believe
that this effect is not due to position effects but ratherbeen demonstrated for LCRs. One such analysis has
been carried out on the human b-globin LCR, which to transcriptional activity imposed by this intergenic re-
gion. The data described in this paper are consistentconsists of five erythroid-specific DNase I±HSS (Gros-
veld et al., 1987). Experiments demonstrated that three with the possibility that there are two regulatory regions
in the CD8 gene locus, one (unidentified as yet but pres-of these sites are individually capabale of directing posi-
tion-independent expression of a linked b-globin gene in ent in the 80 kb genomic fragment containing the locus)
that determines the expression of the CD8a and CD8btransgenic mice, though not necessarily when a single
copy of the transgene has integrated (Philipsen et al., genes in the immature DP thymocytes, and another
(DNase I±HSS cluster CIII) that regulates CD8ab gene1990; Talbot et al., 1990; Pruzina et al., 1991; Talbot and
Grosveld, 1991). In analogy, DNase I±HSS CIII-1 and expression, after or coincidentally with positive selec-
tion of thymocytes in the CD81 T cell lineage. If oneCIII-2 are each capable of directing subset-specific ex-
pression of a linked CD8a/Lyt-2.2 reporter gene; how- postulates that there is no complete overlap of activity
of the two putative regulatory regions, there may be aever, mice carrying a single copy of each of these
Intergenic Region Control of CD8 Gene Expression
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Flow Cytometryperiod in the life of a thymocyte destined to become
For flow cytometry, 106 thymocytes or lymphocytes were stainedCD81 SP during which the immature control element
with the following antibodies in the appropriate combinations: Fluo-has decreased its transcriptional activity and the mature
rescein isocyanate (FITC)±conjugated anti-CD8a (YTS-169), FITC-
control element has not been fully activated. This could conjugated anti-CD8a/Lyt-2.1 (49±11.1), FITC-conjugated anti-abTCR
explain the existence of intermediate cells with low ex- (H57), phycoerythrin-conjugated anti-CD4 (H129.19) (Boehringer
Mannheim), biotin-conjugated anti-CD8a/Lyt-2.2 (2.43), biotin-con-pression levels of the CD8 coreceptor, which, upon fur-
jugated anti-hCD2 (MAR206, gift of D. Cantrell, Imperial Cancerther maturation, up-regulate the expression of CD8 to
Research Fund, London) and allophycocyanin-conjugated anti-the levels found in mature CD8 SP T cells.
CD8a (53±6.7) (Pharmingen). Cells stained with biotin-conjugated
antibodies were subsequently stained with a second layer of strep-
tavidin±red 670 (Gibco±BRL) for three-color staining orstreptavidin±Experimental Procedures
red 613 (Gibco±BRL) for four-color staining. Three- and four-color
fluorometric analysis was carried out on FACScan and FACSVan-DNase I Hypersensitivity
tage Laser Instruments (Becton Dickinson), respectively, and ana-For DNase I hypersensitivity analysis nuclei were isolated from 2 3
lyzed using Cell Quest software (Becton Dickinson).108 thymocytes and treated with DNase I as described previously
(Greaves et al., 1989). DNA was separated by horizontal gel electro-
phoresis andtransferred to nylon membranes according to Southern Acknowledgments
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The 5.5 kb HindIII genomic fragment containing the CD8a/Lyt-2.2
allele was subcloned from the P1 clone P1±5 (Hostert et al., 1997)
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